Corrigendum: Correction of Acknowledgments. Metformin and Cervical Cancer Risk in Patients with Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea

Article information

Endocrinol Metab. 2023;38(1):174-174

Publication date (electronic) : 2023 January 25

doi : https://doi.org/10.3803/EnM.2023.101

Hyun Min Kim ¹, Min Jin Kang ², Sun Ok Song^,³

¹Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Chung-Ang University, Seoul, Korea

²Research Institute of National Health Insurance Service Ilsan Hospital, Goyang, Korea

³Division of Endocrinology and Metabolism, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea

Corresponding author: Sun Ok Song. Division of Endocrinology and Metabolism, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, 100 Ilsan-ro, Ilsandong-gu, Goyang 10444, Korea Tel: +82-31-900-3470, Fax: +82-31-900-0519 E-mail: songsun7777@gmail.com

Endocrinol Metab 2022;37:929-37

https://doi.org/10.3803/EnM.2022.1613

This corrects the article “Metformin and cervical cancer risk in patients with newly diagnosed type 2 diabetes: a population-based study in Korea” in volume 37 on page 929.

There was an error in our recently published article in the Acknowledgments section, which should be revised as follows:

ACKNOWLEDGMENTS

This work was supported by the National Health Insurance Ilsan Hospital grant (NHIMC-2016-20-011).

We would like to apologize for any inconvenience or misunderstanding.

Article information Continued

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.